Bio-Connect
Linzagolix [935283-04-8]

Linzagolix [935283-04-8]

T27837
TargetMol Chemicals
Estimated Purity99.68%
Product group Chemicals
Molecular Weight508.42
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    TargetMol Chemicals
  • Product Name
    Linzagolix [935283-04-8]
  • Delivery Days Customer
    4
  • Certification
    Research Use Only
  • Chemical Name
    Linzagolix
  • Estimated Purity
    99.68%
  • Molecular Formula
    C22H15F3N2O7S
  • Molecular Weight
    508.42
  • Scientific Description
    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for approval for uterine fibroids, is in phase III clinical trials for endometriosis, and is in phase II clinical studies for adenomyosis.
  • Shelf life instruction
    3 years
  • SMILES
    COc1cc(F)c(cc1OCc1c(OC)ccc(F)c1F)-n1c(=O)[nH]c2csc(C(O)=O)c2c1=O
  • Storage Instruction
    -20°C
  • UNSPSC
    12352200